help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jockers, R.
Right arrow Articles by Strosberg, A. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jockers, R.
Right arrow Articles by Strosberg, A. D.
Endocrinology Vol. 139, No. 6 2676-2684
Copyright © 1998 by The Endocrine Society


ARTICLES

Desensitization of the ß-Adrenergic Response in Human Brown Adipocytes1

Ralf Jockers, Tarik Issad, Vladimir Zilberfarb, Pierre de Coppet, Stefano Marullo and A. Donny Strosberg

CNRS-UPR 0415 and Université Paris VII, Institut Cochin de Génétique Moléculaire, F-75014 Paris, France

Address all correspondence and requests for reprints to: Dr. Ralf Jockers, Laboratoire d’Immuno-Pharmacologie Moléculaire, Institut Cochin de Génétique Moléculaire, 22 rue Méchain, F-75014 Paris, France. E-mail: jockers{at}icgm.cochin.inserm.fr

Activation of adenylyl cyclase by ß-adrenergic receptors (ßARs) plays a major role in adipose tissue homeostasis. The increase in cAMP promotes lipolysis in white adipose tissue, activates both thermogenesis and lipolysis in brown adipose tissue (BAT), and induces BAT hypertrophy. Previous studies indicated that among the three ßAR subtypes present in adipose tissue, ß3AR could be a potential target for antiobesity treatments in humans. We studied immortalized human brown adipocytes (PAZ6 adipocytes) as a model of ß-adrenergic response in human BAT. PAZ6 adipocytes and freshly isolated mature human brown adipocytes display the same proportions of ßAR subtypes, with ß3AR being the most abundant (~80% of the total). However, ß3AR was poorly coupled to the adenylyl cyclase pathway in PAZ6 cells, contributing to only 10% of the isoproterenol-induced accumulation of cAMP, whereas 20% and 70% of the signal depended on ß1- and ß2-subtypes, respectively. Upon isoproterenol stimulation, ß1- and ß2AR down-regulated with a half-life of about 3 h and the ß3AR with a half-life of 30–40 h. Long term stimulation with both saturating (micromolar) and nonsaturating (nanomolar) concentrations of ß-adrenergic agonists caused a complete desensitization of the ß-adrenergic response at the adenylyl cyclase level and loss of stimulated protein kinase A activity and CREB phosphorylation. These results suggest that cAMP-dependent processes will be desensitized upon permanent treatment with ß3AR agonists. Further studies should establish whether the ß3AR is coupled to other signaling pathways in human brown adipocytes and whether these may contribute to BAT hypertrophy and/or thermogenesis.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
J.-L. Guillaume, A. M. Daulat, P. Maurice, A. Levoye, M. Migaud, L. Brydon, B. Malpaux, C. Borg-Capra, and R. Jockers
The PDZ Protein Mupp1 Promotes Gi Coupling and Signaling of the Mt1 Melatonin Receptor
J. Biol. Chem., June 13, 2008; 283(24): 16762 - 16771.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Breit, M. Lagace, and M. Bouvier
Hetero-oligomerization between {beta}2- and {beta}3-Adrenergic Receptors Generates a {beta}-Adrenergic Signaling Unit with Distinct Functional Properties
J. Biol. Chem., July 2, 2004; 279(27): 28756 - 28765.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Couturier and R. Jockers
Activation of the Leptin Receptor by a Ligand-induced Conformational Change of Constitutive Receptor Dimers
J. Biol. Chem., July 11, 2003; 278(29): 26604 - 26611.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
A. C. Bianco, D. Salvatore, B. Gereben, M. J. Berry, and P. R. Larsen
Biochemistry, Cellular and Molecular Biology, and Physiological Roles of the Iodothyronine Selenodeiodinases
Endocr. Rev., February 1, 2002; 23(1): 38 - 89.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
L. Brydon, L. Petit, P. Delagrange, A. D. Strosberg, and R. Jockers
Functional Expression of MT2 (Mel1b) Melatonin Receptors in Human PAZ6 Adipocytes
Endocrinology, October 1, 2001; 142(10): 4264 - 4271.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
J. Zhou, M. Xia Shi, T. D. Mitchell, G. N. Smagin, S. R. Thomas, D. H. Ryan, and R. B.S. Harris
Changes in Rat Adipocyte and Liver Glucose Metabolism Following Repeated Restraint Stress
Experimental Biology and Medicine, April 1, 2001; 226(4): 312 - 319.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
P. Penfornis, S. Viengchareun, D. Le Menuet, F. Cluzeaud, M.-C. Zennaro, and M. Lombes
The mineralocorticoid receptor mediates aldosterone-induced differentiation of T37i cells into brown adipocytes
Am J Physiol Endocrinol Metab, August 1, 2000; 279(2): E386 - E394.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. A. Konkar, S. S. Vansal, G. Shams, P. F. Fraundorfer, W.-P. Zheng, V. I. Nikulin, J. D. L. Angeles, R. H. Fertel, D. D. Miller, and D. R. Feller
beta -Adrenoceptor Subtype Activities of Trimetoquinol Derivatives: Biochemical Studies on Human beta -Adrenoceptors Expressed in Chinese Hamster Ovary Cells
J. Pharmacol. Exp. Ther., November 1, 1999; 291(2): 875 - 883.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
C. C. Gerhardt, J. Gros, A. D. Strosberg, and T. Issad
Stimulation of the Extracellular Signal-Regulated Kinase 1/2 Pathway by Human Beta-3 Adrenergic Receptor: New Pharmacological Profile and Mechanism of Activation
Mol. Pharmacol., February 1, 1999; 55(2): 255 - 262.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1998 by The Endocrine Society